Literature DB >> 16676748

An overview of Medicare reimbursement regulations for advanced practice nurses.

Michael A Frakes1, Tracylain Evans.   

Abstract

The federal government spends nearly 15% of the budget on Medicare services annually, and advanced practice nurses are eligible for reimbursement from that pool. The regulations governing reimbursement are complex because of the social, political, and financial pressures involved in their development. Although economic viability and due diligence considerations make it incumbent on advanced practice nurses to understand the rules, the profession, as a whole, has knowledge deficits in this area. The essentials of regulatory development and structure are reviewed and considerations for optimizing reimbursement are described.

Mesh:

Year:  2006        PMID: 16676748

Source DB:  PubMed          Journal:  Nurs Econ        ISSN: 0746-1739            Impact factor:   1.085


  4 in total

1.  Health care reform and the federal transformation initiatives: capitalizing on the potential of advanced practice psychiatric nurses.

Authors:  Nancy P Hanrahan; Kathleen Delaney; Elizabeth Merwin
Journal:  Policy Polit Nurs Pract       Date:  2010-08

2.  Cost-Effectiveness of Advanced Practice Nurses Compared to Physician-Led Care for Chronic Diseases: A Systematic Review.

Authors:  Cilgy M Abraham; Allison A Norful; Patricia W Stone; Lusine Poghosyan
Journal:  Nurs Econ       Date:  2019 Nov-Dec       Impact factor: 1.193

3.  Association of Private Equity Acquisition of Physician Practices With Changes in Health Care Spending and Utilization.

Authors:  Yashaswini Singh; Zirui Song; Daniel Polsky; Joseph D Bruch; Jane M Zhu
Journal:  JAMA Health Forum       Date:  2022-09-02

4.  Hospital Performance Indicators and Their Associated Factors in Acute Child Poisoning at a Single Poison Center, Central Saudi Arabia.

Authors:  Menyfah Q Alanazi; Majed I Al-Jeriasy; Mohammed H Al-Assiri; Lara Y Afesh; Fahad Alhammad; Mahmoud Salam
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.